Erratum: Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum

Theranostics. 2019 Jun 19;9(16):4595-4596. doi: 10.7150/thno.36746. eCollection 2019.

Authors

Maximilian Klingler¹, Clemens Decristoforo¹, Christine Rangger¹, Dominik Summer¹, Julie Foster², Jane K Sosabowski², Elisabeth von Guggenberg¹

Affiliations

¹ Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.
² Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.

Abstract

[This corrects the article DOI: 10.7150/thno.24378.].

Publication types

Published Erratum

Grants and funding

P 27844/FWF_/Austrian Science Fund FWF/Austria